This presentation will discuss value assessment—including the use of cost-effectiveness and budgetary impact analyses in decision-making—and will contrast approaches taken in other high-income countries with those in the United States. Daniel Ollendorf will touch on what is included in the umbrella term “value-based pricing,” and will discuss under what circumstances various approaches to negotiation, such as outcomes-based contracting, amortized payments, and negotiated discounts, may or may not be value based.
#PHForum2018. LIVE STREAMING AVAILABLE at www.bu.edu/sph/live
Speaker: Daniel Ollendorf, Institute for Clinical and Economic Review (ICER)
Wednesday, March 21, 2018, 4:30 to 6:00 p.m.
For more information on the event, go to: